Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company engages in the manufacture, marketing, distribution, and sale of finished pharmaceutical formulations, active pharmaceutical ingredients etc
Intas Pharmaceuticals Limited, is an unlisted public company incorporated on 31 May, 1985. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 175.47 cr and the total paid-up capital is INR 114.77 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ICICI Bank Limited
No. of Loans: 1
Total Amount : 750.0 cr
Dena Bank
No. of Loans: 1
Total Amount : 4.5 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Urmish Hasmukh Chudgar
Shareholder
|
00096080 | 28 years |
Managing Director | Binish Hasmukh Chudgar
Shareholder
|
00119503 | 40 years |
Whole-time Director | Hasmukh Chudgar
Shareholder
|
00172265 | 40 years |
Director | Sanjay Kukreja | 00175427 | 5 years |
Managing Director | Nimish Hasmukh Bhai Chudgar
Shareholder
|
00212400 | 40 years |
Whole-time Director | Jayesh Shantilal Shah
Shareholder
|
02681464 | 7 years |
Nominee Director | Ratnasami Venkatesh | 03433678 | 10 years |
Kmp | Rakesh Bamzai | <HIDDEN> | 0 years |
Director | Archana Ravindrarai Dholakia | 07935065 | 2 years |
CS | Manoj Narayanan Nair | <HIDDEN> | 18 years |
Kmp | Abhimanyu Ojha | <HIDDEN> | 0 years |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Accord Healthcare Limited, UK | United Kingdom | - | - |
Astron Research Limited, UK | United Kingdom | - | - |
Accord Healthcare Inc., North Carolina, USA | United States | - | - |
Accord Healthcare (Pty) Limited, South Africa | South Africa | - | - |
Accord Farmaceutica Ltda., Brazil | Brazil | - | - |
Accord Healthcare SAC, Peru | Peru | - | - |
Accord Farma S.A. De C.V., Mexico | Mexico | - | - |
Accord Healthcare Inc., Canada | Canada | - | - |
Accord Healthcare Pty, Ltd, Australia | Australia | - | - |
Intas Third Party Sales 2005 S.L. | Spain | - | - |
Farmabiot S.A DE CV, Mexico (2) | Mexico | - | - |
Essential Pharmaceuticals LLC(3) | United States | - | - |
Accord Biopharma Inc. USA (3) | United States | - | - |
Accord Healthcare SAS, France (1) | France | - | - |
Accord Healthcare BV, Netherlands (1) | Netherlands | - | - |
Accord Healthcare Sociedad Limitada, Spain (1) | Spain | - | - |
Accord Healthcare Italia SRL, Italy (1) | Italy | - | - |
Accord Healthcare Polska Spolka Z Organiczona Odpowiedzialnoscia, Poland (1) | Poland | - | - |
Accord Healthcare AB, Sweden (1) | Sweden | - | - |
Accord Healthcare GmbH, Austria (1) | Austria | - | - |
Accord Healthcare OY, Finland (1) | Finland | - | - |
Accord Healthcare Ireland Limited, Ireland (1) | Ireland | - | - |
Accord Healthcare BVPA, Belgium (1) | Belgium | - | - |
Accord Healthcare Limited, Malta (1) | Malta | - | - |
Accord Healthcare GmbH, Germany (1) | Germany | - | - |
Accord Healthcare SDN BHD, Mayalsia (1) | Malaysia | - | - |
Accord Healthcare MENA JLT, UAE (1) | United Arab Emirates | - | - |
Accord Healthcare S.R.O., Czech Republic (1) | Czech Republic | - | - |
Accord Healthcare Private limited, Singapore (1) | Singapore | - | - |
Accord Healthcare, Unipessoal, Lda (1) | Portugal | - | - |
Accord Healthcare HK Limited, Hongkong (1) | Hong Kong | - | - |
Accord Healthcare SRL, Romania (1) | Romania | - | - |
Accord Healthcare AG, Switzerland(1) | Switzerland | - | - |
Accord Healthcare Thailand Limited (Thailand)(1) | Thailand | - | - |
Accord UK Limited, UK | United Kingdom | - | - |
Accord Healthcare Kenya Limited, Kenya | Kenya | - | - |
SM HERBALS PRIVATE LIMITED | Gujarat | 1993 | ₹ 1.2 Cr |
Accord Biosimilars LLC | United States | - | - |
Accord-Healthcare Kft. | Hungary | - | - |
Accord Healthcare Single Member S.A. (Greece) | Greece | - | - |
The incorporation date of INTAS PHARMACEUTICALS LIMITED is 31 May, 1985
The authorized share capital of INTAS PHARMACEUTICALS LIMITED is INR ₹ 175.5 Cr.
The paid-up capital of INTAS PHARMACEUTICALS LIMITED is INR ₹ 114.8 Cr.
The registered address of INTAS PHARMACEUTICALS LIMITED is Corporate House, Near Sola Bridge, S. G. Highway, Thaltej NA Ahmedabad Ahmedabad Gujarat - 380054
The CIN number of INTAS PHARMACEUTICALS LIMITED is U24231GJ1985PLC007866.